Mercola.com brings up an article. Evidently there is more to the
story.
Personally, he doesn't hold a candle to Dr. Hill and the wonderful
scientists that we have on the doTerra science board. I am so
impressed with their professionalism and willingness to teach us with
kindness. Amen to your comment Monica!
Julia
On Oct 28, 11:29 am, jcm...@aol.com wrote:
> You might find this very interesting....and follow the link at the end as well,
> Jan In Florida <><
>
> 10.28.2009
>
> Dr Mercola, a MD, states on
> an email I received from a friend:
>
> "A study published in
> the Lancet just found that influenza vaccination was NOT
> associated with a reduced risk of pneumonia in older people. Why is this
> important? Because 35,000 of the 36,000 "flu" deaths the government claims
> happen each year are actually caused by diseases like pneumonia, and NOT the
> flu
>
> ·
> Giving young children
> flu shots appeared to have no impact on flu-related doctor visits or
> hospitalizations during two recent flu seasons, according to a study published
> in the October issue of the Archives of Pediatric &
> Adolescent Medicine. This link opens up Dr
> Mercola's website.
>
> ·
> The flu vaccine is no
> more effective for children than a placebo, according to a large-scale,
> systematic review of 51 studies,
> published in the Cochrane Database of Systematic
> Reviews. Dr Mercola is plagiarizing this information. See the actual
> study abstract below.
>
> ·
> NO studies have conclusively proven that flu shots prevent flu-related deaths among
> the elderly. For this statement, Dr
> Mercola is quoting his own website.
>
> ·
> A study published in the Lancet just found that influenza vaccination was NOT
> associated with a reduced risk of pneumonia in older people. Why is this
> important? Because 35,000 of the 36,000 "flu" deaths the government claims happen
> each year are actually caused by diseases like pneumonia, and NOT the flu. Again, DrMercola is plagiarizing the information,
> as pneumonia is a consequence of influenza, as the medical profession knows.
>
> ·
> Research published in
> the American Journal of Respiratory and
> Critical Care Medicine
> also confirms that there has been no decrease in deaths from influenza and
> pneumonia, despite the fact that vaccination coverage among the elderly has
> increased from 15 percent in 1980 to 65 percent now. Please read the original study abstract below. The
> red highlights are mine.
>
> For even more information, studies and
> statistics about the flu shot, please review this previous article."
>
> My (Jeannie
> Boyle) investigation reveals the following, using the links supplied by Dr
> Mercola: (red highlights are added by me)
>
> Vaccines
> for preventing influenza in healthy children.Smith
> S, Demicheli V,
> Di Pietrantonj C,
> Harnden AR,
> Jefferson T,
> Matheson NJ,
> Rivetti A.
>
> Oxford University, Institute of Health
> Sciences, Old Road Headington, Oxford, UK, OX3 7LF.
> sue.sm...@public-health.oxford.ac.uk
> BACKGROUND: In children and adults the consequences of influenza are
> mainly absences from school and work, however the risk of complications is
> greatest in children and people over 65 years old. OBJECTIVES: To appraise all
> comparative studies evaluating the effects of influenza vaccines in healthy
> children; assess vaccine efficacy (prevention of confirmed influenza) and
> effectiveness (prevention of influenza-like illness) and document adverse
> events associated with receiving influenza vaccines. SEARCH STRATEGY: We
> searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The
> Cochrane Library Issue 1, 2005); OLD MEDLINE (1966 to 1969); MEDLINE (1969 to
> December 2004); EMBASE (1974 to December 2004); Biological Abstracts (1969 to
> December 2004); and Science Citation Index (1974 to December 2004). We wrote to
> vaccine manufacturers and a number of corresponding authors of studies in the
> review. SELECTION CRITERIA: Any randomised controlled trials (RCTs), cohort and
> case-control studies of any influenza vaccine in healthy children under 16 years
> old. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial
> quality and extracted data. MAIN RESULTS: Fifty-one studies involving 263,987
> children were included. Seventeen papers were translated from Russian. Fourteen
> RCTs and 11 cohort studies were included in the analysis of vaccine efficacy
> and effectiveness. From RCTs, live vaccines showed an efficacy of 79% (95%
> confidence interval (CI) 48% to 92%) and an effectiveness of 33% (95% CI 28% to
> 38%) in children older than two years compared with placebo or no intervention.
> Inactivated vaccines had a lower efficacy of 59% (95% CI 41% to 71%) than live
> vaccines but similar effectiveness: 36% (95% CI 24% to 46%). In children under
> two, the efficacy of inactivated vaccine was similar to placebo. Thirty-four
> reports containing safety outcomes were included, 22 including live vaccines, 8
> inactivated vaccines and 4 both types. The most commonly presented short-term
> outcomes were temperature and local reactions. The variability in design of studies
> and presentation of data was such that meta-analysis of safety outcome data was
> not feasible. AUTHORS' CONCLUSIONS: Influenza
> vaccines are efficacious in children older than two years but little evidence
> is available for children under two. There
> was a marked difference between vaccine efficacy and effectiveness. That no
> safety comparisons could be carried out emphasizes the need for standardisation
> of methods and presentation of vaccine safety data in future studies. It was
> surprising to find only one study of inactivated vaccine in children under two
> years, given recent recommendations to vaccinate healthy children from six
> months old in the USA and Canada. If immunisation in children is to be
> recommended as public-health policy, large-scale studies assessing important
> outcomes and directly comparing vaccine types are urgently required.
>
> PMID: 16437500 [PubMed - indexed
> for MEDLINE
>
> The Dr Oz link displays:
> "PAGE NOT FOUND" –Here Dr Mercola is providing a dead-end
> link.
>
> ______________________________________________________________________________
>
> Am J
> Respir Crit Care Med. 2008 Sep 1;178(5):527-33. Epub 2008 Jun 12. Mortality reduction with
> influenza vaccine in patients with pneumonia outside "flu" season:
> pleiotropic benefits or residual confounding? Eurich
> DT, Marrie
> TJ, Johnstone
> J, Majumdar
> SR. Department of Public Health Sciences, School of Public Health,
> University of Alberta, 13-103 Clinical Sciences Bldg., Edmonton, AB, T6G 2G3
> Canada. deur...@ualberta.ca Comment in: Am J
> Respir Crit Care Med. 2008 Sep 1;178(5):439-40.
>
> RATIONALE: Observational studies
> suggest a 50% mortality reduction for older patients receiving influenza
> vaccination; some deem this magnitude of benefit implausible and invoke
> confounding by the "healthy user effect" as an alternate explanation.
> OBJECTIVES: To evaluate unrecognized confounding by hypothesizing the presence
> of a 50% mortality reduction with vaccination for patients with pneumonia outside of
> influenza season. METHODS: Clinical, laboratory, and functional data were
> prospectively collected on 1,813 adults with community-acquired pneumonia
> admitted to six hospitals outside of influenza season in the Capital Health
> region (AB, Canada). Vaccination status was ascertained by interview and chart
> review. Outcome
> was in-hospital mortality. Influenza-vaccinated patients were
> matched to a nonvaccinated control using propensity scores, and then
> multivariable regression was used to determine the independent association
> between vaccination and mortality. MEASUREMENTS AND MAIN RESULTS: The cohort
> consisted of 352 vaccine recipients and 352 matched control subjects. Most
> (85%) patients were 65 years or older, 29% had severe pneumonia, and 12% died. Influenza
> vaccination was associated with a 51% mortality reduction (28 of 352 [8%] died
> vs. 53 of 352 [15%] control subjects; unadjusted odds ratio [OR],
> 0.49; 95% confidence interval [CI], 0.30-0.79; P = 0.004) outside influenza
> season. Adjustment for age, sex, and comorbidities did not alter these findings
> (adjusted OR, 0.45; 95% CI, 0.27-0.76). More complete adjustment for
> confounding (e.g., functional and socioeconomic status) markedly attenuated
> these benefits and their statistical significance (adjusted OR, 0.81; 95% CI,
> 0.35-1.85; P = 0.61). CONCLUSIONS: The 51% reduction in mortality with
> vaccination initially observed in patients with pneumonia who did not have
> influenza was most likely a result of confounding. Previous observational
> studies may have overestimated mortality benefits of influenza vaccination.
>
> PMID: 18556629 [PubMed - indexed for
> MEDLINE]
>
> Please have a look at the link below:
>
> http://www.quackwatch.org/04ConsumerEducation/nonrecperiodicals.html
--~--~---------~--~----~------------~-------~--~----~
You received this message because you are subscribed to the Google
Groups "Everything doTERRA" group.
To post to this group, send email to everythingdoterra@googlegroups.com
To unsubscribe from this group, send email to
everythingdoterra+unsubscribe@googlegroups.com
For more options, visit this group at
http://www.everythingdoterra.com
-~----------~----~----~----~------~----~------~--~---
No comments:
Post a Comment